Skip to main content
LLM 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Session VIII: Indolent Lymphomas and CAR-T Cells

Debate: Patients with Recurrent Follicular Lymphoma Should Receive CAR-T Cells vs Bispecific Antibodies - BISPECIFIC ANTIBODIES

Thursday, October 19, 2023
4:40 PM – 4:55 PM ET
Location: Metropolitan East